ÂÜÀòÂÒÂ×

TJ Cradick, Ph.D., is a leading expert in gene editing and cell therapy, currently serving as Chief Scientific Officer and Principal at Gene Editing Frontiers LLC while providing advisory services to Eucalyptus Bio and Catalytic Data Science. Previously, TJ held the position of Chief Scientific Officer at Excision BioTherapeutics, focusing on CRISPR-based therapies for viral diseases. With extensive experience in genome editing technologies from roles at CRISPR Therapeutics and the Georgia Institute of Technology, TJ has authored numerous publications and holds multiple patents. Academic credentials include a Ph.D. in Molecular and Cellular Biology from the University of Iowa, an MA in Immunology from the University of California, San Francisco, and a BS in Life Sciences from the Massachusetts Institute of Technology.